THECOMPOUND

Search

Search guides, news, and programs

Compare
Home / Guides / Semaglutide vs Tirzepatide

Last updated April 2026 · How we research

Semaglutide vs tirzepatide: which is better for weight loss?

Tirzepatide shows stronger average weight loss in clinical trials. Semaglutide is more widely available and generally cheaper. Both work by reducing appetite. Here's what the data actually says and how to pick between them.

The gist

  • Tirzepatide led to ~21% average weight loss in SURMOUNT-1; semaglutide ~15% in STEP 1.
  • Both reduce appetite; tirzepatide adds a second receptor (GIP) on top of GLP-1.
  • Semaglutide is usually cheaper and more widely available, so the choice often comes down to cost and goals.

Side-by-side comparison

FactorSemaglutideTirzepatide
MechanismGLP-1 agonistGLP-1 + GIP dual agonist
Brand namesOzempic, WegovyMounjaro, Zepbound
Avg weight loss (trials)~12–15%~15–22%
Compounded cost (online)~$150–$350/mo~$250–$500/mo
Injection frequencyOnce weeklyOnce weekly
Online availabilityVery widely availableAvailable, but fewer programs
Common side effectsNausea, GI upsetNausea, GI upset (similar)

Trial data from STEP 1 (NEJM, 2021) and SURMOUNT-1 (NEJM, 2022).

2026 update: The FDA approved Wegovy HD (semaglutide 7.2mg) in March 2026. The STEP UP trial showed 20.7% mean weight loss at 72 weeks — nearly matching tirzepatide's numbers in separate trials. The two drugs have not been compared head-to-head.

Which should you start with?

Start with semaglutide if:

  • • Budget is a concern — semaglutide is meaningfully cheaper per month
  • • You want maximum availability and provider options
  • • You're new to GLP-1s and want to start with the more established option

Consider tirzepatide if:

  • • Maximizing weight loss is the primary goal and cost is less of a factor
  • • You've tried semaglutide with limited response and want to try the dual-action mechanism
  • • Your provider recommends it based on your health profile

Decided on a drug? Find the program for it.

Answer 3 questions and get your best-match program in about 30 seconds.

Find your match →

Frequently Asked Questions

Get the 2026 GLP-1 Cost & Eligibility Cheat Sheet

One page: real monthly costs for compounded vs brand semaglutide and tirzepatide, the BMI thresholds that qualify you, and the five questions to ask before you pay. We'll email it now.

No spam. Unsubscribe anytime.

Sources

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021.
  2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022.
Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Peptides and GLP-1 medications require a prescription and should only be taken under the supervision of a licensed healthcare provider. Individual results vary. Always consult a doctor before starting any new medication or compound.
The Compound app

The Compound app

Track your protocol, read the research, and stay on top of what's new in GLP-1s and peptides.

Download